Biovie BIVI
NASDAQ BIVI
$1.46 -0.01 (-0.68%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biovie (BIVI) Selling, General & Administrative (2013 - 2026)

Updated

Biovie's Selling, General & Administrative came in at $2.13 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 10.4% from $2.38 million a year earlier and down 0.8% from the prior quarter.

Analysis

Biovie (BIVI) Selling, General & Administrative (2013 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Biovie's Selling, General & Administrative was $8.51 million, down 0.7% from FY2025.

  • Selling, General & Administrative has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 12.9% (FY2021 to FY2026).
  • Going back by fiscal year, Selling, General & Administrative was $8.57 million in FY2025 (-3.2%), $8.85 million in FY2024 (-23.4%), $11.55 million in FY2023 (+18.3%) and $9.77 million in FY2022 (+110.6%).
  • The five-year range for quarterly Selling, General & Administrative is $1.59 million (fiscal Q3 2025) to $4.4 million (fiscal Q2 2023).
  • Year-over-year, Selling, General & Administrative increased in four of the last eight quarters, with growth averaging 0.1%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in fiscal Q1 2022 (growth of 948.2%), and the weakest in fiscal Q2 2024 (a decline of 48.8%).
  • Business Quant data shows BIVI's Selling, General & Administrative at $2.15 million (Q3 2026), $1.94 million (Q2 2026) and $2.29 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Biovie 11.01 Mn 11.01 Mn - 2.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.13 Mn
Mar 31, 2026 2.15 Mn
Dec 31, 2025 1.94 Mn
Sep 30, 2025 2.29 Mn
Jun 30, 2025 2.38 Mn
Mar 31, 2025 1.59 Mn
Dec 31, 2024 2.53 Mn
Sep 30, 2024 2.08 Mn
Jun 30, 2024 2.68 Mn
Mar 31, 2024 1.97 Mn
Dec 31, 2023 2.25 Mn
Sep 30, 2023 1.94 Mn
Jun 30, 2023 2.62 Mn
Mar 31, 2023 2.52 Mn
Dec 31, 2022 4.40 Mn
Sep 30, 2022 2.01 Mn
Jun 30, 2022 3.36 Mn
Mar 31, 2022 2.11 Mn
Dec 31, 2021 1.89 Mn
Sep 30, 2021 2.40 Mn
API Access

Biovie Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BIVI&period=max&api_key=YOUR_API_KEY